Cibus, Inc. (CBUS) États Financiers et Données Historiques

Cibus, Inc. (CBUS) — Prix $1.51 HealthcareBiotechnology — NASDAQ

Derniers résultats publiés:

États financiers détaillés de Cibus, Inc. (CBUS): compte de résultat, bilan et tableau de flux de trésorerie. Suivez l'évolution des marges, de la dette, de la liquidité et de la rentabilité d'une année sur l'autre avec jusqu'à 20 ans d'historique.

Résumé de l'Analyse

Cibus, Inc. a enregistré un chiffre d'affaires de $3.6M sur le dernier exercice, avec un CAGR sur 5 ans de -31.3%.

Marges des 12 derniers mois: marge brute 45.7%, marge opérationnelle -12.4%, marge nette -22.6%.

Au prix actuel de $1.51, CBUS affiche des résultats négatifs (PER non significatif) et un ROE de -320.60%. La capitalisation boursière s'établit à $115M.

Compte de Résultat (10 ans)

Année2016201720182019202020212022202320242025
Revenus$399000$508000$236000$7.3M$23.9M$26.0M$157000$1.8M$4.3M$3.6M
Coût des Ventes$200000$551000$1.1M$9.3M$35.1M$28.6M$1.5M$395000$6.9M$5.9M
Marge Brute$199000-$43000-$845000-$2.0M-$11.3M-$2.6M-$1.4M$1.4M-$2.6M-$2.3M
R&D$5.6M$11.6M$9.8M$12.2M$11.1M$11.3M$11.6M$42.4M$50.4M$44.2M
Frais Généraux$6.7M$14.7M$18.5M$24.1M$20.8M$15.4M$9.4M$28.9M$30.8M$26.9M
Charges Opérationnelles$12.3M$25.7M$27.3M$37.7M$32.6M$26.8M$21.0M$320.3M$74.4M$65.2M
Résultat Opérationnel-$12.1M-$25.8M-$28.1M-$39.7M-$43.8M-$29.3M-$22.4M-$318.9M-$77.0M-$67.5M
EBITDA-$11.7M-$25.2M-$25.6M-$36.5M-$41.5M-$25.4M-$15.2M-$314.6M-$241.6M-$90.8M
Charges d'Intérêt$5000$1000$1.3M$1.5M$1.4M$1.4M$87000$18.9M$34.2M$35.5M
Résultat Avant Impôts-$12.1M-$26.0M-$27.9M-$39.6M-$44.8M-$29.2M-$16.9M-$337.6M-$282.7M-$132.2M
Impôts0000000-$4000$29000$29000
Résultat Net-$12.1M-$26.0M-$27.9M-$39.6M-$44.8M-$29.2M-$16.9M-$267.6M-$251.4M-$127.1M
BPA$-21.86$-46.86$-45.46$-60.37$-66.16$-38.96$-18.36$-25.95$-10.83$-2.78
BPA Dilué$-21.86$-46.86$-45.46$-60.37$-66.16$-38.96$-18.36$-25.95$-10.83$-2.78
Actions en Circulation (Diluées)$553000$554375$613668$656113$677648$749515$919950$10.3M$23.2M$45.8M

Compte de Résultat (Trimestriel)

Année2025-Q32025-Q42026-Q12026-Q2
Revenus$615000$1.1M$1.7M$994000
Marge Brute$615000$1.1M$484000-$168000
Résultat Opérationnel-$15.4M-$13.5M-$12.1M-$12.9M
EBITDA-$15.3M-$21.2M-$10.9M-$11.5M
Résultat Net-$23.5M-$31.3M-$21.2M-$22.1M
BPA$-0.44$-0.59$-0.33$-0.29
BPA Dilué$-0.44$-0.59$-0.33$-0.29

Bilan (10 ans)

Année2016201720182019202020212022202320242025
Trésorerie$5.0M$56.7M$93.8M$58.6M$17.3M$13.8M$3.4M$32.7M$14.4M$9.9M
Placements à Court Terme0000$11.7M00000
Créances$157000$167000$46000$1.1M$4.9M00$530000$1.0M$703000
Stocks000$2.6M$1.4M00000
Actifs Courants$5.5M$57.5M$95.5M$63.5M$39.6M$15.2M$4.1M$35.2M$16.9M$12.1M
Immobilisations Corporelles$11.0M$14.4M$21.9M$23.2M$22.9M$21.7M$18.1M$37.5M$44.7M$27.9M
Goodwill0000000$434.9M$253.5M$232.5M
Actifs Incorporels000000$158000$35.4M$33.6M$31.7M
Actifs Totaux$16.6M$72.2M$118.8M$88.1M$63.3M$37.2M$22.4M$544.4M$350.1M$305.0M
Dettes Fournisseurs$357000$1.0M$818000$1.1M$929000$1.3M$340000$6.1M$6.0M$8.1M
Dette à Court Terme0000000$833000$436000$3.2M
Passifs Courants$2.9M$4.3M$7.0M$7.2M$6.9M$4.9M$1.7M$21.3M$19.9M$16.9M
Dette à Long Terme0000$1.5M00$536000$226000$235.0M
Passifs Totaux$3.5M$14.7M$25.4M$25.6M$26.5M$23.1M$15.2M$206.1M$252.2M$283.2M
Réserves-$28.6M-$54.5M-$82.4M-$122.1M-$166.9M-$196.1M-$212.2M-$479.8M-$731.2M-$858.3M
Capitaux Propres$13.1M$57.5M$93.4M$62.5M$36.9M$14.1M$7.2M$293.5M$92.2M$21.8M
Dette Totale0$10.1M$18.5M$18.6M$19.8M$17.9M$13.9M$24.6M$36.3M$268.0M
Dette Nette-$5.0M-$46.5M-$75.3M-$40.0M-$9.2M$4.1M$10.5M-$8.1M$21.9M$258.0M
Fonds de Roulement$2.6M$53.2M$88.5M$56.3M$32.6M$10.3M$2.5M$13.9M-$2.9M-$4.8M

Bilan (Trimestriel)

Année2025-Q32025-Q42026-Q12026-Q2
Trésorerie$23.9M$9.9M$30.3M$20.4M
Actifs Totaux$330.2M$305.0M$324.2M$313.4M
Passifs Totaux$278.2M$283.2M$288.7M$298.6M
Capitaux Propres$50.4M$21.8M$35.5M$14.8M
Dette Totale$33.9M$268.0M$276.2M$32.7M

Tableau de Flux (10 ans)

Année2016201720182019202020212022202320242025
Résultat Net-$12.1M-$26.0M-$27.9M-$39.6M-$44.8M-$29.2M-$16.9M-$267.6M-$282.7M-$127.1M
Amortissements$345000$551000$1.1M$1.6M$1.9M$2.3M$1.5M$4.7M$6.9M$5.9M
Stock-based Compensation$948000$12.1M$4.4M$9.2M$5.0M$2.1M$4.0M$16.1M$10.8M$8.2M
Variation du BFR$1.6M$552000$2.2M-$3.1M-$5.7M$7.5M-$2.9M$961000$383000$2.3M
Cash Flow Opérationnel-$9.2M-$12.8M-$20.3M-$32.0M-$43.7M-$18.8M-$19.4M-$46.2M-$58.0M-$50.6M
CapEx-$10.4M-$779000-$1.8M-$3.0M-$1.8M-$497000-$1.5M-$4.3M-$808000-$578000
Acquisitions0000000$59.4M00
Rachat d'Actions00-$2300000000000
Dividendes Payés0000000000
Free Cash Flow-$19.7M-$13.6M-$22.1M-$34.9M-$45.5M-$19.3M-$20.9M-$50.5M-$58.9M-$51.2M

Tableau de Flux (Trimestriel)

Année2025-Q32025-Q42026-Q12026-Q2
Cash Flow Opérationnel-$11.7M-$13.4M-$11.5M-$9.4M
CapEx-$108000-$86000-$115000$42000
Free Cash Flow-$11.8M-$13.5M-$11.6M-$9.4M
Dividendes Payés0000
Stock-based Compensation$1.9M$1.8M$1.6M$1.5M

Croissance et Marges (10 ans)

Année2016201720182019202020212022202320242025
Croissance Revenus (annuelle)+27.3%-53.5%+2991.5%+226.9%+9.0%-99.4%+1057.3%+134.6%-14.6%
Croissance Résultat Net (annuelle)-115.0%-7.4%-42.0%-13.2%+34.9%+42.2%-1484.4%+6.1%+49.4%
Croissance BPA (annuelle)-114.4%+3.0%-32.8%-9.6%+41.1%+52.9%-41.3%+58.3%+74.3%
Variation Actions (annuelle)+0.2%+10.7%+6.9%+3.3%+10.6%+22.7%+1021.2%+125.1%+97.0%
Croissance FCF (annuelle)+31.0%-62.9%-58.0%-30.2%+57.5%-8.2%-142.0%-16.5%+13.1%
Marge Brute49.9%-8.5%-358.1%-27.2%-47.3%-9.9%-877.1%78.3%-60.9%-62.8%
Marge Opérationnelle-3034.8%-5076.6%-11913.1%-543.8%-183.8%-112.9%-14248.4%-17550.0%-1805.8%-1853.9%
Marge EBITDA-2941.4%-4954.3%-10830.1%-500.5%-174.1%-97.9%-9687.9%-17313.4%-5669.5%-2494.3%
Marge Nette-3029.1%-5114.2%-11820.8%-542.9%-188.0%-112.4%-10758.6%-14729.1%-5898.4%-3492.3%
Marge FCF-4927.6%-2670.1%-9364.0%-478.6%-190.6%-74.3%-13301.9%-2781.0%-1380.8%-1406.1%
Taux d'Imposition Effectif-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%0.0%-0.0%-0.0%

Données par Action (10 ans)

Année2016201720182019202020212022202320242025
FCF par Action$-35.55$-24.47$-36.01$-53.22$-67.08$-25.76$-22.70$-4.90$-2.53$-1.12
Dividende par Action$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Actions en Circulation (Basiques)$553000$554375$613668$656113$677648$749515$919950$10.3M$23.2M$45.8M

Quoi regarder en Biotech

La plupart des petites biotechs perdent de l'argent. Les analyser avec le P/E n'a aucun sens — regardez cash et pipeline.

Rentabilité

Rentabilité des capitaux propres-320.60%
Rentabilité du capital investi-17.82%
Rentabilité des actifs-31.33%
Marge brute45.73%
Marge opérationnelle-1240.90%
Marge nette-2258.89%

Santé financière

Dette / Capitaux propres2.21
Ratio de liquidité1.62

Ratios Clés (10 ans)

Année2016201720182019202020212022202320242025
PER-25.73-25.02-11.39-5.81-3.19-2.73-0.40-0.76-0.26-0.63
P/B23.7111.313.403.683.885.650.940.690.703.65
P/V779.611279.541346.9531.525.993.0743.36111.4915.1521.88
Marge Brute49.9%-8.5%-358.1%-27.2%-47.3%-9.9%-877.1%78.3%-60.9%-62.8%
Marge Opérationnelle-3034.8%-5076.6%-11913.1%-543.8%-183.8%-112.9%-14248.4%-17550.0%-1805.8%-1853.9%
Marge Nette-3029.1%-5114.2%-11820.8%-542.9%-188.0%-112.4%-10758.6%-14729.1%-5898.4%-3492.3%

Entreprises liées: ACRV · BMEA · CAMP · IMUX · MNOV · PMVP · RLMD

Explorer le secteur: Healthcare · Biotechnology

Plus de sections de CBUS: Vue d'ensemble · Valorisation · Statistiques · Estimations · Technique · Actionnariat · Actualités · Événements

Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions